Početna › Debljina › New Jersey
Kliničke studije za Debljina u državi New Jersey
20 studija za Debljina traži sudionike na lokacijama u državi New Jersey.
Gradovi u državi New Jersey
Službeni tekst studije (engleski)
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Somerset
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Hackensack University Medical Center, Hackensack
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Hypertension & Nephrology Association, Eatontown
- IMA Clinical Research Warren, Warren Township
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Eatontown
- Research Site, Somerset
- Research Site, Warren Township
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- CardioMetabolic Collaborative Clinic, Somerset
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- IMA Clinical Research Warren, Warren Township
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07321886A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Jersey City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Virtua Health Incorporated, Marlton
- Saint Michaels Medical Center, Newark
- CardioMetabolic Collaborative Clinic, Somerset
U tijeku regrutacijaFaza 3
Od 18 do 99 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07037459A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Clinical Research of Philadelphia, Pennington
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06897475A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Premier Research, Trenton
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07215559A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Psoriasis Treatment Center of Central New Jersey, East Windsor
- Care Access - Hoboken, Hoboken
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06857942Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Premier Research, Trenton
U tijeku regrutacijaFaza 3
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684144A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Jersey City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07784725A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Heart House - Vineland, Elmer
- Advanced Cardiology LLC - Hackettstown, Hackettstown
- The Heart House Haddon Heights, Haddon Heights
- i još 5
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07567001Metabolic Health, Bones and Nuts During Weight Loss in Adults
- Rutgers University - NJ Inst Food Nutrition & Health, New Brunswick
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 50 do 75 godina · Oba spola · Ažurirano 13. svi 2026. · NCT06949280A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
- Vanda Investigational Site, Hamilton
U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 20. tra 2026. · NCT07446439A Study of a Weight Loss Intervention in People With Endometrial Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Žene · Ažurirano 13. tra 2026. · NCT06751589A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
- Frontage Clinical Services, Inc., Secaucus
U tijeku regrutacijaFaza 1
Od 18 do 65 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT07465965Extracellular Vesicles, Insulin Action, and Exercise
- Institute for Food, Nutrition, and Health, New Brunswick
- Robert Wood Johnson University Hospital Clinical Research Center, New Brunswick
- Rutgers University Loree Gymnasium, New Brunswick
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 30 do 80 godina · Oba spola · Ažurirano 23. sij 2026. · NCT06546085IVIG vs SCIG in CIDP
- Rutgers, The State University of New Jersey Clinical Research Center, New Brunswick
U tijeku regrutacijaFaza 1
Od 18 do 65 godina · Oba spola · Ažurirano 11. pro 2025. · NCT05584631Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.